The Prognostic Value of Lymph Node Involvement after Neoadjuvant Chemotherapy Is Different among Breast Cancer Subtypes

The Prognostic Value of Lymph Node Involvement after Neoadjuvant Chemotherapy Is Different among Breast Cancer Subtypes

Introduction: The three different breast cancer subtypes (Luminal, <i>HER2-</i>positive, and triple negative (TNBCs) display different natural history and sensitivity to treatment, but little is known about whether residual axillary disease after neoadjuvant chemotherapy (NAC) carries a...

Full description

Bibliographic Details
Main Authors: Lucie Laot, Enora Laas, Noemie Girard, Elise Dumas, Eric Daoud, Beatriz Grandal, Jean-Yves Pierga, Florence Coussy, Youlia Kirova, Elsy El-Alam, Guillaume Bataillon, Marick Lae, Florence Llouquet, Fabien Reyal, Anne-Sophie Hamy
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
breast cancer
neoadjuvant chemotherapy
prognostic
residual axillary disease
nodal involvement
number of positive nodes
Online Access:https://www.mdpi.com/2072-6694/13/2/171

Internet

https://www.mdpi.com/2072-6694/13/2/171

Similar Items